IBDEI01B ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1175,2)
 ;;=^19944
 ;;^UTILITY(U,$J,358.3,1176,0)
 ;;=780.31^^9^83^29
 ;;^UTILITY(U,$J,358.3,1176,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1176,1,4,0)
 ;;=4^780.31
 ;;^UTILITY(U,$J,358.3,1176,1,5,0)
 ;;=5^Convulsions, Febrile
 ;;^UTILITY(U,$J,358.3,1176,2)
 ;;=^28172
 ;;^UTILITY(U,$J,358.3,1177,0)
 ;;=331.0^^9^83^31
 ;;^UTILITY(U,$J,358.3,1177,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1177,1,4,0)
 ;;=4^331.0
 ;;^UTILITY(U,$J,358.3,1177,1,5,0)
 ;;=5^Dementia, Alzheimer's
 ;;^UTILITY(U,$J,358.3,1177,2)
 ;;=^5679^294.10
 ;;^UTILITY(U,$J,358.3,1178,0)
 ;;=291.2^^9^83^30
 ;;^UTILITY(U,$J,358.3,1178,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1178,1,4,0)
 ;;=4^291.2
 ;;^UTILITY(U,$J,358.3,1178,1,5,0)
 ;;=5^Dementia, Alcoholic
 ;;^UTILITY(U,$J,358.3,1178,2)
 ;;=^268015
 ;;^UTILITY(U,$J,358.3,1179,0)
 ;;=290.40^^9^83^32
 ;;^UTILITY(U,$J,358.3,1179,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1179,1,4,0)
 ;;=4^290.40
 ;;^UTILITY(U,$J,358.3,1179,1,5,0)
 ;;=5^Dementia, Multi-Infarct
 ;;^UTILITY(U,$J,358.3,1179,2)
 ;;=^303487
 ;;^UTILITY(U,$J,358.3,1180,0)
 ;;=290.0^^9^83^34
 ;;^UTILITY(U,$J,358.3,1180,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1180,1,4,0)
 ;;=4^290.0
 ;;^UTILITY(U,$J,358.3,1180,1,5,0)
 ;;=5^Dementia, Senile
 ;;^UTILITY(U,$J,358.3,1180,2)
 ;;=^31703
 ;;^UTILITY(U,$J,358.3,1181,0)
 ;;=780.4^^9^83^110
 ;;^UTILITY(U,$J,358.3,1181,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1181,1,4,0)
 ;;=4^780.4
 ;;^UTILITY(U,$J,358.3,1181,1,5,0)
 ;;=5^Vertigo
 ;;^UTILITY(U,$J,358.3,1181,2)
 ;;=^35946
 ;;^UTILITY(U,$J,358.3,1182,0)
 ;;=345.90^^9^83^105
 ;;^UTILITY(U,$J,358.3,1182,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1182,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,1182,1,5,0)
 ;;=5^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,1182,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,1183,0)
 ;;=355.1^^9^83^75
 ;;^UTILITY(U,$J,358.3,1183,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1183,1,4,0)
 ;;=4^355.1
 ;;^UTILITY(U,$J,358.3,1183,1,5,0)
 ;;=5^Meralgia Paresthetica
 ;;^UTILITY(U,$J,358.3,1183,2)
 ;;=^265141
 ;;^UTILITY(U,$J,358.3,1184,0)
 ;;=340.^^9^83^83
 ;;^UTILITY(U,$J,358.3,1184,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1184,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,1184,1,5,0)
 ;;=5^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,1184,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,1185,0)
 ;;=729.2^^9^83^84
 ;;^UTILITY(U,$J,358.3,1185,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1185,1,4,0)
 ;;=4^729.2
 ;;^UTILITY(U,$J,358.3,1185,1,5,0)
 ;;=5^Neuropathic Pain
 ;;^UTILITY(U,$J,358.3,1185,2)
 ;;=Neuropathic Pain^82605
 ;;^UTILITY(U,$J,358.3,1186,0)
 ;;=053.19^^9^83^92
 ;;^UTILITY(U,$J,358.3,1186,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1186,1,4,0)
 ;;=4^053.19
 ;;^UTILITY(U,$J,358.3,1186,1,5,0)
 ;;=5^Post-Herpetic Neuralgia
 ;;^UTILITY(U,$J,358.3,1186,2)
 ;;=^266544
 ;;^UTILITY(U,$J,358.3,1187,0)
 ;;=310.9^^9^83^85
 ;;^UTILITY(U,$J,358.3,1187,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1187,1,4,0)
 ;;=4^310.9
 ;;^UTILITY(U,$J,358.3,1187,1,5,0)
 ;;=5^Organic Brain Syndrome
 ;;^UTILITY(U,$J,358.3,1187,2)
 ;;=^123952
 ;;^UTILITY(U,$J,358.3,1188,0)
 ;;=332.0^^9^83^88
 ;;^UTILITY(U,$J,358.3,1188,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1188,1,4,0)
 ;;=4^332.0
 ;;^UTILITY(U,$J,358.3,1188,1,5,0)
 ;;=5^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,1188,2)
 ;;=Parkinson's Disease^304847
 ;;^UTILITY(U,$J,358.3,1189,0)
 ;;=250.60^^9^83^89
 ;;^UTILITY(U,$J,358.3,1189,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1189,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,1189,1,5,0)
 ;;=5^Peripheral Neuropathy, Diabetic
 ;;^UTILITY(U,$J,358.3,1189,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,1190,0)
 ;;=356.9^^9^83^91
 ;;^UTILITY(U,$J,358.3,1190,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1190,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,1190,1,5,0)
 ;;=5^Peripheral Neuropathy, Unsp
 ;;^UTILITY(U,$J,358.3,1190,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,1191,0)
 ;;=780.2^^9^83^106
 ;;^UTILITY(U,$J,358.3,1191,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1191,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,1191,1,5,0)
 ;;=5^Syncope Or Presyncope
 ;;^UTILITY(U,$J,358.3,1191,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,1192,0)
 ;;=724.3^^9^83^102
 ;;^UTILITY(U,$J,358.3,1192,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1192,1,4,0)
 ;;=4^724.3
 ;;^UTILITY(U,$J,358.3,1192,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,1192,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,1193,0)
 ;;=780.39^^9^83^103
 ;;^UTILITY(U,$J,358.3,1193,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1193,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,1193,1,5,0)
 ;;=5^Seizure
 ;;^UTILITY(U,$J,358.3,1193,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,1194,0)
 ;;=782.0^^9^83^87
 ;;^UTILITY(U,$J,358.3,1194,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1194,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,1194,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,1194,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,1195,0)
 ;;=435.9^^9^83^107
 ;;^UTILITY(U,$J,358.3,1195,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1195,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,1195,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,1195,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,1196,0)
 ;;=354.2^^9^83^109
 ;;^UTILITY(U,$J,358.3,1196,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1196,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,1196,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,1196,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,1197,0)
 ;;=729.1^^9^83^35
 ;;^UTILITY(U,$J,358.3,1197,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1197,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,1197,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,1197,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,1198,0)
 ;;=438.20^^9^83^11
 ;;^UTILITY(U,$J,358.3,1198,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1198,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,1198,1,5,0)
 ;;=5^CVA w/Hemiplegia (late effect)
 ;;^UTILITY(U,$J,358.3,1198,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,1199,0)
 ;;=438.12^^9^83^8
 ;;^UTILITY(U,$J,358.3,1199,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1199,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,1199,1,5,0)
 ;;=5^CVA w/Dysphasia (late effect)
 ;;^UTILITY(U,$J,358.3,1199,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,1200,0)
 ;;=356.8^^9^83^90
 ;;^UTILITY(U,$J,358.3,1200,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1200,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,1200,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;^UTILITY(U,$J,358.3,1200,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,1201,0)
 ;;=337.20^^9^83^100
 ;;^UTILITY(U,$J,358.3,1201,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1201,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,1201,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,1201,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,1202,0)
 ;;=294.8^^9^83^33
 ;;^UTILITY(U,$J,358.3,1202,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1202,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,1202,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,1202,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,1203,0)
 ;;=438.6^^9^83^7
 ;;^UTILITY(U,$J,358.3,1203,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1203,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,1203,1,5,0)
 ;;=5^CVA w/Dysesthesia (late effect)
 ;;^UTILITY(U,$J,358.3,1203,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,1204,0)
 ;;=438.7^^9^83^26
 ;;^UTILITY(U,$J,358.3,1204,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1204,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,1204,1,5,0)
 ;;=5^CVA w/Vision Changes (late effect)
 ;;^UTILITY(U,$J,358.3,1204,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,1205,0)
 ;;=438.84^^9^83^5
 ;;^UTILITY(U,$J,358.3,1205,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1205,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,1205,1,5,0)
 ;;=5^CVA w/Ataxia (late effect)
 ;;^UTILITY(U,$J,358.3,1205,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,1206,0)
 ;;=434.91^^9^83^27
 ;;^UTILITY(U,$J,358.3,1206,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1206,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,1206,1,5,0)
 ;;=5^CVA, Acute Onset
 ;;^UTILITY(U,$J,358.3,1206,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,1207,0)
 ;;=333.94^^9^83^101
 ;;^UTILITY(U,$J,358.3,1207,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1207,1,4,0)
 ;;=4^333.94
 ;;^UTILITY(U,$J,358.3,1207,1,5,0)
 ;;=5^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,1207,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,1208,0)
 ;;=345.90^^9^83^104
 ;;^UTILITY(U,$J,358.3,1208,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1208,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,1208,1,5,0)
 ;;=5^Seizure Disorder
 ;;^UTILITY(U,$J,358.3,1208,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,1209,0)
 ;;=907.0^^9^83^73
 ;;^UTILITY(U,$J,358.3,1209,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1209,1,4,0)
 ;;=4^907.0
 ;;^UTILITY(U,$J,358.3,1209,1,5,0)
 ;;=5^Late Effect Intracranial Injury
 ;;^UTILITY(U,$J,358.3,1209,2)
 ;;=^68489
 ;;^UTILITY(U,$J,358.3,1210,0)
 ;;=339.00^^9^83^43
 ;;^UTILITY(U,$J,358.3,1210,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1210,1,4,0)
 ;;=4^339.00
 ;;^UTILITY(U,$J,358.3,1210,1,5,0)
 ;;=5^Headache,Cluster NOS
 ;;^UTILITY(U,$J,358.3,1210,2)
 ;;=^336741
 ;;^UTILITY(U,$J,358.3,1211,0)
 ;;=339.01^^9^83^42
 ;;^UTILITY(U,$J,358.3,1211,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1211,1,4,0)
 ;;=4^339.01
 ;;^UTILITY(U,$J,358.3,1211,1,5,0)
 ;;=5^Headache,Cluster Episodic
 ;;^UTILITY(U,$J,358.3,1211,2)
 ;;=^336545
 ;;^UTILITY(U,$J,358.3,1212,0)
 ;;=339.02^^9^83^41
 ;;^UTILITY(U,$J,358.3,1212,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1212,1,4,0)
 ;;=4^339.02
 ;;^UTILITY(U,$J,358.3,1212,1,5,0)
 ;;=5^Headache,Cluster Chronic
 ;;^UTILITY(U,$J,358.3,1212,2)
 ;;=^336546
 ;;^UTILITY(U,$J,358.3,1213,0)
 ;;=339.03^^9^83^65
 ;;^UTILITY(U,$J,358.3,1213,1,0)
 ;;=^358.31IA^5^2
